Skip to content

products

AUTOMATED ACTUATORS

Vereo ® Actuator NSx

Unrivaled Accuracy in Automated Actuation

With configurations available to accommodate vertically-actuated, side-actuated, and dual side-actuated nasal and oral spray devices, Vereo® actuators save time and manpower while eliminating the errors inherent in manual testing. An ideal solution for product development as well as QC and release testing, the platform offers unmatched data quality, high throughput and valuable insight into the overall performance your device.

Uniform, Consistent Actuation—Every Time

  • Robust, proven functionality lets you model human usage of your product, ensuring precise control of important actuation parameters, including force limit, position, velocity, acceleration, and timing
  • Electromechanical design offers superior control, accuracy and precision—no compressed air or vacuum required
  • Can operate as a standalone benchtop unit or within a Proveris platform, Laser Diffraction System (DSD), or other analytical instruments 
  • Together with Viota® software, offers valuable insight into valve performance, and lets you investigate position and force profiles for each actuation

One Solution for All Your Required Tests :

Vereo actuators provide robust, automated actuation; the preferred method for completing regulatory required in vitro tests. The Vereo actuator can be used to provide fully controllable and repeatable actuation for the following commonly required tests:

  • Spray pattern
  • Plume geometry
  • Pump delivery
  • Droplet size distribution (DSD) by Laser Diffraction
  • Dose content uniformity (DCU), through life
  • Priming/Re-priming
  • Automated actuation with positional or force-limited accuracy, precision, and repeatability; compliant with U.S. FDA guidelines
  • Powerful, yet simple to use user interface with real time force-position feedback measured and displayed as actuation profiles
  • User selectable stroke length, contact and end of stroke force limits, actuation velocity/acceleration, hold time, and release velocity/acceleration
  • Technical controls to enable compliance with U.S. 21 CFR Part 11

Access current, relevant resources for respiratory drug development & quality control.

Ensure uninterrupted operation with on-site and remote support from experienced engineers.

Make informed decisions with study results & consultations with our application scientists.

request a callback

From a Proveris Sales Associate